327 related articles for article (PubMed ID: 11526457)
1. Electrotransfer of naked DNA in the skeletal muscles of animal models of muscular dystrophies.
Vilquin JT; Kennel PF; Paturneau-Jouas M; Chapdelaine P; Boissel N; Delaère P; Tremblay JP; Scherman D; Fiszman MY; Schwartz K
Gene Ther; 2001 Jul; 8(14):1097-107. PubMed ID: 11526457
[TBL] [Abstract][Full Text] [Related]
2. High-efficiency plasmid gene transfer into dystrophic muscle.
Gollins H; McMahon J; Wells KE; Wells DJ
Gene Ther; 2003 Mar; 10(6):504-12. PubMed ID: 12621454
[TBL] [Abstract][Full Text] [Related]
3. Full-length dystrophin cDNA transfer into skeletal muscle of adult mdx mice by electroporation.
Murakami T; Nishi T; Kimura E; Goto T; Maeda Y; Ushio Y; Uchino M; Sunada Y
Muscle Nerve; 2003 Feb; 27(2):237-41. PubMed ID: 12548532
[TBL] [Abstract][Full Text] [Related]
4. Full-length dystrophin gene transfer to the mdx mouse in utero.
Reay DP; Bilbao R; Koppanati BM; Cai L; O'Day TL; Jiang Z; Zheng H; Watchko JF; Clemens PR
Gene Ther; 2008 Apr; 15(7):531-6. PubMed ID: 18273052
[TBL] [Abstract][Full Text] [Related]
5. Restoration of dystrophin expression in mdx mice by intravascular injection of naked DNA containing full-length dystrophin cDNA.
Liang KW; Nishikawa M; Liu F; Sun B; Ye Q; Huang L
Gene Ther; 2004 Jun; 11(11):901-8. PubMed ID: 14985786
[TBL] [Abstract][Full Text] [Related]
6. Gene delivery to dystrophic muscle.
Wells KE; McMahon J; Foster H; Ferrer A; Wells DJ
Methods Mol Biol; 2008; 423():421-31. PubMed ID: 18370219
[TBL] [Abstract][Full Text] [Related]
7. Myoblast transplantations lead to the expression of the laminin alpha 2 chain in normal and dystrophic (dy/dy) mouse muscles.
Vilquin JT; Guérette B; Puymirat J; Yaffe D; Tomé FM; Fardeau M; Fiszman M; Schwartz K; Tremblay JP
Gene Ther; 1999 May; 6(5):792-800. PubMed ID: 10505103
[TBL] [Abstract][Full Text] [Related]
8. A highly functional mini-dystrophin/GFP fusion gene for cell and gene therapy studies of Duchenne muscular dystrophy.
Li S; Kimura E; Ng R; Fall BM; Meuse L; Reyes M; Faulkner JA; Chamberlain JS
Hum Mol Genet; 2006 May; 15(10):1610-22. PubMed ID: 16595609
[TBL] [Abstract][Full Text] [Related]
9. Mini-dystrophin gene transfer in mdx4cv diaphragm muscle fibers increases sarcolemmal stability.
Decrouy A; Renaud JM; Davis HL; Lunde JA; Dickson G; Jasmin BJ
Gene Ther; 1997 May; 4(5):401-8. PubMed ID: 9274716
[TBL] [Abstract][Full Text] [Related]
10. Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice.
Lochmüller H; Petrof BJ; Pari G; Larochelle N; Dodelet V; Wang Q; Allen C; Prescott S; Massie B; Nalbantoglu J; Karpati G
Gene Ther; 1996 Aug; 3(8):706-16. PubMed ID: 8854096
[TBL] [Abstract][Full Text] [Related]
11. Long-term expression of full-length human dystrophin in transgenic mdx mice expressing internally deleted human dystrophins.
Ferrer A; Foster H; Wells KE; Dickson G; Wells DJ
Gene Ther; 2004 Jun; 11(11):884-93. PubMed ID: 14985788
[TBL] [Abstract][Full Text] [Related]
12. Mini- and full-length dystrophin gene transfer induces the recovery of nitric oxide synthase at the sarcolemma of mdx4cv skeletal muscle fibers.
Decrouy A; Renaud JM; Lunde JA; Dickson G; Jasmin BJ
Gene Ther; 1998 Jan; 5(1):59-64. PubMed ID: 9536265
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow transplantation improves outcome in a mouse model of congenital muscular dystrophy.
Hagiwara H; Ohsawa Y; Asakura S; Murakami T; Teshima T; Sunada Y
FEBS Lett; 2006 Aug; 580(18):4463-8. PubMed ID: 16859688
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of plasmid-mediated gene therapy for muscular dystrophy by directed plasmid integration.
Bertoni C; Jarrahian S; Wheeler TM; Li Y; Olivares EC; Calos MP; Rando TA
Proc Natl Acad Sci U S A; 2006 Jan; 103(2):419-24. PubMed ID: 16387861
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (MDX) mice.
Yang L; Lochmuller H; Luo J; Massie B; Nalbantoglu J; Karpati G; Petrof BJ
Gene Ther; 1998 Mar; 5(3):369-79. PubMed ID: 9614557
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic improvement of dystrophic muscles by rAAV/microdystrophin vectors is augmented by Igf1 codelivery.
Abmayr S; Gregorevic P; Allen JM; Chamberlain JS
Mol Ther; 2005 Sep; 12(3):441-50. PubMed ID: 16099410
[TBL] [Abstract][Full Text] [Related]
17. Expression of laminin alpha1, alpha2, alpha4, and alpha5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice.
Ringelmann B; Röder C; Hallmann R; Maley M; Davies M; Grounds M; Sorokin L
Exp Cell Res; 1999 Jan; 246(1):165-82. PubMed ID: 9882526
[TBL] [Abstract][Full Text] [Related]
18. Electroporation of corrective nucleic acids (CNA) in vivo to promote gene correction in dystrophic muscle.
Kapsa RM; Wong SH; Quigley AF
Methods Mol Biol; 2008; 423():405-19. PubMed ID: 18370218
[TBL] [Abstract][Full Text] [Related]
19. Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin.
Rooney JE; Welser JV; Dechert MA; Flintoff-Dye NL; Kaufman SJ; Burkin DJ
J Cell Sci; 2006 Jun; 119(Pt 11):2185-95. PubMed ID: 16684813
[TBL] [Abstract][Full Text] [Related]
20. Restoration of all dystrophin protein interactions by functional domains in trans does not rescue dystrophy.
Gardner KL; Kearney JA; Edwards JD; Rafael-Fortney JA
Gene Ther; 2006 May; 13(9):744-51. PubMed ID: 16307000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
